Is Berberine Glucose Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Berberine Glucose Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Berberine lowers both lipids and glucose, yet its role on cardiometabolic disease risk remain unclear. [Zhao JV (2026); evidence level 2] - Based on a randomized controlled trial of berberine (registered in ClinicalTrials.gov on Dec 2018, NCT03770325), leveraging proteomics and sex hormones data, we built a signature reflecting response to berberine using elastic net regression. [Zhao JV (2026); evidence level 2] - Following the successful reduction in deficiency-related disorders, from the 1950s onward, the focus in affluent societies increasingly shifted toward chronic non-communicable diseases associated with modern lifestyles []. [Háber Andor Zsolt (2026); evidence level 4] - In an effort to mitigate the risk of such diseases, the concept of functional foods emerged. [Háber Andor Zsolt (2026); evidence level 4] - In the contemporary digital era, and increasingly on the basis of individual characteristics (including formulations aimed at optimizing blood glucose levels), FS have become tools of individualized, personalized health support, with all their associated advantages and potential drawbacks []. [Háber Andor Zsolt (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.